ORCID
- Banerjee, Sube: 0000-0002-8083-7649
- Farina, Nicolas: 0000-0002-0635-2547
DOI
10.1016/s0140-6736(21)01210-1
Publication Date
2021-10-21
Publication Title
The Lancet
Volume
398
Issue
10310
ISSN
0140-6736
Embargo Period
2022-03-08
Organisational Unit
Peninsula Medical School
First Page
1487
Last Page
1497
Recommended Citation
Banerjee, S., High, J., Stirling, S., Shepstone, L., Swart, A., Telling, T., Henderson, C., Ballard, C., Bentham, P., Burns, A., Farina, N., Fox, C., Francis, P., Howard, R., Knapp, M., Leroi, I., Livingston, G., Nilforooshan, R., Nurock, S., O'Brien, J., Price, A., Thomas, A., & Tabet, N. (2021) 'Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial', The Lancet, 398(10310), pp. 1487-1497. Available at: https://doi.org/10.1016/s0140-6736(21)01210-1
